Coelenterazine (CTZ) Differences and an Application Overview

Coelenterazine (Coelenterazine, CTZ, CAS 55779-48-1) is a representative marine luciferin that is widely used as the substrate and light-emitting chromophore for multiple marine luciferases and the jellyfish photoprotein (Aequorin). By tuning spectral position, emission intensity, reaction kinetics, stability, and cell permeability, different coelenterazine analogs can be matched to reporter-gene assays, BRET energy-transfer analysis, high-sensitivity Ca2+ detection, and ROS/RNS-related chemiluminescence readouts.

Keywords: Coelenterazine; CTZ; Aequorin; luciferase; BRET; calcium; bioluminescence; ROS

I. Basic Information and Physicochemical Properties

1.1 Nomenclature and core parameters

Coelenterazine is commonly abbreviated as CTZ (CAS 55779-48-1), with molecular formula C26H21N3O3 and molecular weight 423.46. It is typically a yellow solid; it is sensitive to light and moisture, and light-protected, airtight storage at −20°C is recommended.

1.2 Summary of physicochemical and structural descriptors

The table below consolidates identifiers, physicochemical parameters, spectral information, and structure descriptors for rapid reference in method development and reagent handling.

Item	Content	Item	Content
CAS No.	55779-48-1	Name	Coelenterazine
English synonyms	Coelenteramine; CLZ-N; CLZN-N; CS-2297; Nanofuel; enterazine; Preluciferin; Coelenterazin; COELENTERAZINE; COELENTERAZINN	CBNumber	CB9162998
Molecular formula	C26H21N3O3	Molecular weight	423.46
MOLFile	55779-48-1.mol	Melting point	176–181°C (decompose)
Boiling point	641.4±65.0°C (Predicted)	Density	1.32±0.1 g/cm³ (Predicted)
Storage	−20°C	Solubility	methanol and ethanol: soluble
pKa	9.91±0.15 (Predicted)	Form	solid
Color	yellow	Sensitivity	Moisture & Light Sensitive
λmax	429 nm	Applications in biology	Calcium indicator; detecting luciferase、protease、gene expression、nucleic acids、proteins、stem cells、quantum dot conjugates、superoxide; tracing protein dynamics; as a substrate for luciferase
InChI	InChI=1S/C26H21N3O3/c30-20-10-6-18(7-11-20)15-23-26(32)29-16-24(19-8-12-21(31)13-9-19)27-22(25(29)28-23)14-17-4-2-1-3-5-17/h1-13,16,27,30-31H,14-15H2	InChIKey	YHIPILPTUVMWQT-UHFFFAOYSA-N
SMILES	C12N=C(CC3=CC=C(O)C=C3)C(=O)N1C=C(C1=CC=C(O)C=C1)NC=2CC1=CC=CC=C1

1.3 Stability and experimental handling

CTZ readily undergoes spontaneous oxidation under light and oxygen, generating background luminescence, and it is also moisture-sensitive. Practical mitigation includes light-protected handling, aliquoting into small volumes, minimizing freeze–thaw cycles, and reducing time at room temperature; the delay from substrate addition to signal acquisition should be standardized and documented to reduce between-run incomparability driven by kinetic differences.

II. Chemiluminescent Mechanism and Determinants of Reaction Performance

2.1 Core pathway of luciferase-catalyzed light emission

Under luciferase catalysis, CTZ reacts with O2 to form a peroxide intermediate and subsequently a high-energy four-membered ring intermediate; ring cleavage releases CO2 and yields an excited-state emitter. Photon emission occurs upon relaxation of the excited state to the ground state, producing measurable bioluminescence. This process typically does not require additional cofactors, which underlies the broad utility of CTZ-based systems.

 

2.2 Key variables governing signal quality

(1) Spontaneous oxidation and background control:

Background should be minimized by light protection, low-temperature handling, aliquoting, and reduced exposure time; prior to plate reading or imaging, verify stability of background levels in blank wells/negative samples.

(2) Solvent compatibility and matrix effects:

Stock-solution solvents must be compatible with cells or enzyme systems; dilution procedures should avoid local high concentrations that can inactivate proteins or induce cytotoxicity; within a batch, use a consistent solvent system and a fixed addition sequence.

(3) Kinetic matching and acquisition parameters:

Reaction rates and peak shapes vary substantially across analogs; integration time, sampling frequency, and detector gain should be matched accordingly to avoid saturation and apparent signal compression, with priority given to operating within the linear response range of the instrument.

III. Native Coelenterazine vs. Analogs: Key Metrics and Selection Logic

3.1 Core differentiating metrics

(1) Spectral properties:

Emission maxima determine channel bleed-through and filter configuration, particularly for BRET and multi-channel readouts.

(2) Luminescence intensity and signal-to-noise:

These govern feasibility in low-expression/weak-signal contexts and short acquisition windows, while also affecting saturation risk.

(3) Reaction kinetics and Ca2+ sensitivity:

These are critical for resolving transient responses and detecting small-amplitude Ca2+ changes in aequorin-based assays.

(4) Stability and cell permeability:

These determine intracellular loading efficiency, reproducibility in in vitro/in vivo settings, and baseline background levels.

3.2 Distinguishing features of representative analogs

(1) Native coelenterazine (CTZ, CAS 55779-48-1):

Broad compatibility and robustness; suitable as a reference substrate for aequorin reconstitution, reporter assays, and baseline BRET workflows, and can also support selected ROS/RNS-related chemiluminescence readouts.

(2) Coelenterazine 400a (CAS 70217-82-2):

Emission near ~400 nm; commonly used in GFP-acceptor BRET configurations to reduce acceptor-channel bleed-through; compatibility with specific luciferase constructs should be validated empirically.

(3) Coelenterazine H (CAS 50909-86-9):

A dehydroxylated analog of native CTZ; often used to achieve higher output and increased Ca2+ sensitivity, supporting detection of subtle Ca2+ fluctuations and improved sensitivity in weak-signal regimes.

(4) Coelenterazine hcp (CAS 123437-32-1):

Can yield very high luminescence and rapid Ca2+ response in aequorin-related systems, enabling low-expression assays or short integration times; substrate concentration and acquisition settings must be tightly controlled to prevent saturation.

(5) Coelenterazine cp:

In some systems, increases output while maintaining a fast rising phase, supporting higher-throughput readouts and time-resolved experimental designs.

(6) Coelenterazine f (CAS 123437-16-1):

Combines relatively strong luminescence with improved cell permeability, supporting intracellular loading while maintaining high Ca2+ sensitivity; often used for live-cell measurements and rapid kinetics acquisition.

(7) Coelenterazine n (analog class):

Generally weaker output and slower Ca2+ kinetics; can be used to reduce sensitivity to expand linear range, mitigate saturation in strong-signal settings, or serve as a kinetic-control substrate.

(8) Coelenterazine e (CAS 114496-02-5):

Rapid aequorin reconstitution in vitro and dual-emission features (e.g., ~405 nm and ~465 nm), enabling ratiometric strategies to improve Ca2+ quantification robustness; lower cell permeability and relatively limited solution stability make it better suited to in vitro systems or specialized quantification workflows.

3.3 Comparative spectral and kinetic parameters across coelenterazine substrates

The table below summarizes emission maxima (Em), RLC1, relative intensity, and half-rise time across representative substrates, supporting preliminary selection and parameter planning for BRET channel design, fast transient capture, and weak-signal amplification.

(1) Methodological meaning of Em (nm)

①Used to evaluate spectral matching between donor emission and acceptor absorption; it is the primary parameter for selecting acceptor fluorescent proteins, filters/spectrometers, and detection channels in BRET.

②Used to assess spectral separation and bleed-through risk; when Em substantially overlaps with acceptor channels, mitigation may require narrower bandwidth filters, alternative acceptors, or substrate substitution to reduce cross-talk.

(2) Comparative meaning of RLC1 and Relative Intensity

①RLC1 can be used to compare relative output or effective light-emission efficiency across substrates under a shared test framework, and is most informative when interpreted together with Relative Intensity to balance "strength–linearity–background".

②Relative Intensity reflects luminescence output under comparable conditions and directly determines detectability in weak-signal systems; when intensity increases substantially, lowering substrate concentration or shortening integration time can reduce auto-oxidation background and saturation risk.

(3) Kinetic meaning of Half-rise time (ms)

①Reports rising-edge speed and time resolution, which is critical for fast Ca2+ transients, rapid receptor activation/inactivation, and high-frequency kinetic sampling.

②When fitting rising-phase kinetic parameters (e.g., rise-rate constants or time-to-peak), shorter half-rise times can improve fit stability but require higher sampling rates and stricter synchronization of substrate addition.

(4) Scenario-based selection guidance

①BRET and multi-channel detection: prioritize Em for spectral matching and minimized bleed-through, then increase Relative Intensity within acceptable background constraints to maximize signal-to-noise.

②Aequorin-Ca2+ measurements: prioritize Half-rise time to match target Ca2+ kinetics, then use Relative Intensity to determine integration time and sampling frequency, while leveraging permeability and stability to reduce drift.

③High-throughput screening: select substrates with moderate-to-high intensity while maintaining linear range and batch-to-batch consistency; standardize substrate addition and fixed readout windows to reduce variance.

Product name	Em (nm)	RLC1	Relative Intensity	Half-rise time (ms)
Native coelenterazine	466	1	1	6–30
Coelenterazine h	466	0.75	16	6–30
Coelenterazine 400a	400
Coelenterazine hcp	445	0.65	500	2–5
Coelenterazine cp	442	0.63	28	2–5
Coelenterazine f	472	0.8	20	6–30
Coelenterazine n	468	0.25	0.15	6–30
Coelenterazine e	405 & 465	0.5	4	0.15–0.3

IV. Application Systems: Differentiated Needs and Methodological Considerations

4.1 Ca2+ sensing: the aequorin complex system

Aequorin emits light upon Ca2+ binding; CTZ, as its chromophore, determines output intensity, Ca2+ sensitivity, and kinetic response. Analog selection should be guided by the target Ca2+ range, transient duration, sampling frequency, and whether ratiometric quantification is used.

(1) Small-amplitude fluctuations and fast transients:

Prioritize high-sensitivity, fast-responding analogs and co-optimize acquisition frequency and integration time.

(2) Improving quantitative robustness:

In vitro systems may leverage dual-emission analogs for ratiometric readouts to reduce system variability.

4.2 Reporter-gene and protein-function assays: substrates for marine luciferases

CTZ-based systems are widely used for gene expression, promoter activity, protein–protein interactions, and protease cleavage assays. Key methodological priorities are background control and matching enzyme–substrate kinetics.

(1) Signal–background separation:

Include substrate-only blanks, negative controls, and positive controls; where appropriate, define standard curves and linear ranges.

(2) Assessment of matrix effects:

Secreted formats or complex sample matrices may alter substrate stability and background; evaluate matrix matching and dilution strategies.

4.3 BRET: energy-transfer measurements without external excitation

BRET depends on spectral matching between donor emission and acceptor absorption and is strongly influenced by bleed-through and filter configuration. Substrate selection should be optimized around donor emission maxima, acceptor-channel interference, decay kinetics, and the intended acquisition window.

(1) Reducing channel bleed-through:

In GFP-acceptor BRET, substrates with emission closer to ~400 nm can be prioritized to reduce interference.

(2) Matching the time window:

Differences in decay profiles and peak shapes require standardized acquisition timing and integration parameters to ensure comparability.

4.4 ROS/RNS-related measurements: oxidative-stress readouts

CTZ can be used for chemiluminescence-based detection of oxidative species in cells or tissues; however, specificity requirements are higher and should be supported by stringent controls and inhibitor/scavenger validation.

(1) Specificity confirmation:

Include scavenger/inhibitor controls to attribute signal origin and assess contributions of metal ions and light exposure to background.

(2) Inter-batch consistency:

Standardize aliquoting, freeze–thaw counts, and exposure times to reduce background drift and batch effects.

4.5 In vivo imaging and pharmacodynamic evaluation

In vivo performance depends not only on substrate chemistry but also on dosing route, biodistribution, and tissue optical properties. Standard operating procedures should define dose, imaging time points, and normalization strategies to reduce inter-individual variability and improve comparability.

V. Practical Use and Quality-Control Recommendations

5.1 Sample handling and storage

(1) Light-protected aliquoting:

Aliquot into small volumes to reduce freeze–thaw cycles and room-temperature exposure.

(2) Low temperature and dryness:

Store at −20°C under light protection and airtight conditions; minimize moisture uptake and light exposure during handling.

5.2 Solution preparation and control design

(1) Stock-solution strategy:

Prioritize high-concentration stocks in methanol/ethanol; dilute immediately before use and minimize residence time in aqueous media.

(2) Control structure:

At minimum include substrate-only blanks, negative controls, and positive controls; for ROS/RNS applications, include inhibitor/scavenger validation.

5.3 Instrument settings and data comparability

(1) Avoid saturation:

For high-output analogs, reduce substrate concentration, shorten integration time, or lower gain to remain within the linear range of the instrument.

(2) Standardize acquisition windows:

Keep sampling time points and integration parameters consistent within an experiment, and record the delay between substrate addition and acquisition to reduce kinetic bias.

VI. Aladdin-related products

6.1 Coelenterazine (CTZ)–Related Product List

Catalog No.	Product Name	CAS No.	Grade and Purity
C131248	Coelenterazine	55779-48-1	≥94%
C580349	Coelenterazine	55779-48-1	10mM in DMSO
C755376	Coelenterazine hcp	123437-32-1	BioReagent, Ultra pure, ≥95%, solid
C332017	Coelenterazine 400 a	70217-82-2	≥95%
C1375499	Coelenterazine	55779-48-1	Suitable for molecular biology, ≥95%(TLC)
C944463	Coelenterazine e	114496-02-5	0
C755371	Coelenterazine fcp	123437-33-2	solid
C1375502	Coelenterazine 400a	70217-82-2	Suitable for molecular biology, ≥95%(TLC)
C1437239	Coelenterazine h hydrochloride	—	≥98%
C1375519	Coelenterazine h	50909-86-9	BioReagent， ≥98%(HPLC)

6.2 Key Determinants of CTZ Bioluminescence and Specificity-Validation Control Reagents

Category	Reagent	CAS No.	Applicable Assays	Relationship to CTZ Signal	Key Notes
Aequorin–Ca²⁺ triggering	Calcium chloride (CaCl2)	10043-52-4	Aequorin–Ca²⁺ calibration curve; dynamic-range calibration	Ca²⁺ directly triggers Aequorin–CTZ bioluminescence, determining peak intensity and kinetics	Prepare fresh; avoid precipitation with phosphate; fix ionic strength
Aequorin–Ca²⁺ triggering	EGTA (ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid)	67-42-5	Low-Ca background; free Ca²⁺ buffering system	Chelates Ca²⁺ to reduce CTZ-triggered emission probability, lowering background and defining buffer windows	Pair with CaCl2 to calculate free Ca²⁺; fix pH
Aequorin loading/permeabilization	Digitonin	11024-24-1	Semi-permeabilization for Aequorin loading / control of intracellular ions	Controlled permeabilization affects Aequorin–CTZ loading and intracellular ionic conditions, altering CTZ emission amplitude	Narrow working window; determine threshold in pilot tests
Aequorin loading/permeabilization	Saponin	8047-15-2	Permeabilization control (alternative to digitonin)	Similarly modulates Aequorin–CTZ loading efficiency and Ca²⁺ accessibility via permeabilization	Strong cell-type dependence; note batch effects
Ca²⁺ kinetics positive control	Ionomycin	56092-81-0	Induce rapid Ca²⁺ elevation; verify CTZ emission upper bound	Rapidly elevates intracellular Ca²⁺ to trigger strong Aequorin–CTZ emission; positive control	Control dose to avoid irreversible damage; fix delay from addition to acquisition
Ca²⁺ store-release control	Thapsigargin	67526-95-8	ER Ca²⁺ store-release model	Reshapes intracellular Ca²⁺ time course, thereby altering CTZ peak shape and decay	Strong stressor; optimize time window and include activity controls
Substrate auto-oxidation amplification	Copper sulfate (CuSO4)	7758-98-7	Metal-catalyzed background-sensitivity testing	Cu²⁺ can catalyze CTZ oxidation, amplifying non-specific background emission for stress testing	Low concentrations can be impactful; must set blank wells
Substrate auto-oxidation amplification	Ferrous sulfate (FeSO4)	7720-78-7	Fenton-related background-sensitivity testing	Fe²⁺ can promote oxidative chain reactions, increasing and drifting CTZ background	Fe²⁺ oxidizes readily; prepare fresh and control oxygen exposure
ROS triggering/validation	Hydrogen peroxide (H2O2)	7722-84-1	ROS-associated CTZ chemiluminescence validation	Provides oxidative pressure to test CTZ chemiluminescence / background rise under ROS	Prepare fresh; decomposition causes dose drift
ROS source validation	Menadione	58-27-5	Cellular superoxide-generation model	Redox cycling elevates O2•− to test whether CTZ signal increases with O2•−	High cytotoxicity; run parallel viability/toxicity readouts
O2•− generation system	Xanthine	69-89-6	In vitro XO system to generate O2•−	Generates O2•− to test CTZ superoxide sensitivity	Requires XO; fix reaction time window
O2•− generation system	Xanthine oxidase (XO)	9002-17-9	In vitro O2•− generation	With xanthine, provides a reproducible O2•− source for CTZ signal-origin validation	Record unit activity; avoid batch-to-batch variation
O2•− specificity control	Superoxide dismutase (SOD)	9054-89-1	(XO system or cells) O2•− scavenging control	Removes O2•−; a decrease in CTZ signal supports a superoxide-driven contribution	Paired design (±SOD) with the generation system
H2O2 specificity control	Catalase	9001-05-2	H2O2 scavenging control	Decomposes H2O2 to assess H2O2 contribution to CTZ signal	Paired design (±catalase) with H2O2
RNS/NO source control	Sodium nitroprusside	13755-38-9	NO donor control; RNS sensitivity validation	Provides NO-related stimulation to test whether CTZ signal is influenced by RNS	Photosensitive; fix delay from addition to acquisition
Substrate/wall-loss control	Bovine serum albumin (BSA)	9048-46-8	In vitro reactions / plate assays to reduce adsorption	Reduces effective-concentration fluctuations and inter-batch drift caused by hydrophobic CTZ adsorption to vessel walls	Grade-dependent; include blanks
Optical path/crosstalk check	Luciferin	2321-07-5	BRET-channel crosstalk and filter leakage check (auxiliary)	Not part of CTZ emission chemistry; used to verify detection-channel leakage that could create false signals	Optical validation only; measure separately from CTZ reactions

CTZ systems are characterized by excitation-free operation, relatively low background, and high sensitivity, yet data quality is highly sensitive to substrate stability management and methodological standardization. Native CTZ is suitable as a robust, general-purpose choice for establishing baseline workflows; when higher demands are placed on spectral cross-talk, transient kinetics, intracellular loading, or quantitative robustness, analogs should be selected based on spectral profile, intensity, kinetics, stability, and permeability, followed by small-scale pilot experiments to fix substrate concentration, addition order, and acquisition parameters. With systematic optimization of substrate handling, control design, and instrument settings, CTZ substrates can deliver reproducible and interpretable results across Ca2+ sensing, reporter-gene assays, BRET studies, and oxidative-stress evaluations.